NCT07659990

Brief Summary

This prospective randomized double-blind controlled trial aims to compare the postoperative analgesic efficacy and dermatomal spread of rhomboid intercostal-subserratus plane (RISS) block and serratus posterior superior intercostal plane (SPSIP) block in patients undergoing modified radical mastectomy. Postoperative pain scores, opioid consumption, rescue analgesic requirements, block-related complications, and quality of recovery outcomes will be evaluated.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable postoperative-pain

Timeline
4mo left

Started Jun 2026

Shorter than P25 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Jun 2026Nov 2026

First Submitted

Initial submission to the registry

June 12, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

June 19, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 22, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

June 24, 2026

Status Verified

June 1, 2026

Enrollment Period

5 months

First QC Date

June 12, 2026

Last Update Submit

June 19, 2026

Conditions

Keywords

Breast NeoplasmsPostoperative PainAnesthesia, Conduction

Outcome Measures

Primary Outcomes (1)

  • Total Postoperative Opioid Consumption

    Total opioid consumption during the first 24 hours after modified radical mastectomy.

    24 hours after surgery

Secondary Outcomes (6)

  • Postoperative Pain Scores

    0-24 hours after surgery

  • Compartmental Pain Scores Using Numeric Rating Scale

    0-24 hours after surgery

  • Dermatomal Sensory Block Distribution

    30 minutes after block performance

  • Quality of Recovery-15 Score

    24 hours after surgery

  • Intraoperative Remifentanil Consumption

    During surgery

  • +1 more secondary outcomes

Study Arms (2)

RISS Block

EXPERIMENTAL

Patients will receive an ultrasound-guided rhomboid intercostal-subserratus plane (RISS) block before modified radical mastectomy for postoperative analgesia.

Procedure: Rhomboid Intercostal-Subserratus Plane Block

SPSIP Block

EXPERIMENTAL

Patients will receive an ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block before modified radical mastectomy for postoperative analgesia.

Procedure: Serratus Posterior Superior Intercostal Plane Block

Interventions

Ultrasound-guided rhomboid intercostal-subserratus plane block performed before modified radical mastectomy for postoperative analgesia.

RISS Block

Ultrasound-guided serratus posterior superior intercostal plane block performed before modified radical mastectomy for postoperative analgesia.

SPSIP Block

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients aged 18-75 years
  • ASA physical status I-III
  • Scheduled for elective unilateral modified radical mastectomy with axillary dissection under general anesthesia
  • Provision of written informed consent

You may not qualify if:

  • Anticoagulant therapy
  • Bleeding diathesis
  • Known allergy to local anesthetics or opioids
  • Infection at the block application site or previous surgery in the block area
  • Cognitive impairment preventing NRS assessment
  • Pregnancy or lactation
  • Chronic opioid use
  • Severe hepatic or renal failure
  • Refusal to participate in the study
  • Technical inability to perform the block or failed block

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bursa City Hospital

Bursa, Nilüfer, 16100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativeBreast Neoplasms

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Mürsel Ekinci, MD

    Bursa City Hospital

    PRINCIPAL INVESTIGATOR
  • Yusuf Alan, MD

    Bursa City Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors will be blinded to group allocation. Regional blocks will be performed by an anesthesiologist not involved in postoperative assessments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized in a 1:1 ratio to receive either a Rhomboid Intercostal-Subserratus Plane (RISS) block or a Serratus Posterior Superior Intercostal Plane (SPSIP) block before modified radical mastectomy. Outcomes will be compared between two parallel groups.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

June 12, 2026

First Posted

June 22, 2026

Study Start

June 19, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

June 24, 2026

Record last verified: 2026-06

Locations